Innate defense regulator peptide 1018 in wound healing and wound infection - Wikidata - awgldk - TriplyDB

Innate defense regulator peptide 1018 in wound healing and wound infection

Innate defense regulator peptide 1018 in wound healing and wound infection

http://www.wikidata.org/entity/Q34373912

about

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models Treatment of Oral Multispecies Biofilms by an Anti-Biofilm Peptide The Frog Skin-Derived Antimicrobial Peptide Esculentin-1a(1-21)NH2 Promotes the Migration of Human HaCaT Keratinocytes in an EGF Receptor-Dependent Manner: A Novel Promoter of Human Skin Wound Healing?Perspectives for clinical use of engineered human host defense antimicrobial peptides Komodo dragon-inspired synthetic peptide DRGN-1 promotes wound-healing of a mixed-biofilm infected wound LL-37-derived peptides eradicate multidrug-resistant Staphylococcus aureus from thermally wounded human skin equivalents Antibiotic adjuvants: diverse strategies for controlling drug-resistant pathogens.Antimicrobial peptides and wound healing: biological and therapeutic considerations Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation.Novel biodegradable porous scaffold applied to skin regeneration.Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model.Immunomodulatory Peptide IDR-1018 Decreases Implant Infection and Preserves Osseointegration.High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides.Cationic bactericidal peptide 1018 does not specifically target the stringent response alarmone (p)ppGpp Peptide design for antimicrobial and immunomodulatory applications.Skin electroporation of a plasmid encoding hCAP-18/LL-37 host defense peptide promotes wound healing.Immune modulation by multifaceted cationic host defense (antimicrobial) peptides.Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections.Therapeutic utility of antibacterial peptides in wound healing.Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses.An Immunomodulatory Peptide Confers Protection in an Experimental Candidemia Murine Model.Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii-infected skin wounds in mice.Clavanin A improves outcome of complications from different bacterial infections Peptide IDR-1002 Inhibits NF-κB Nuclear Translocation by Inhibition of IκBα Degradation and Activates p38/ERK1/2-MSK1-Dependent CREB Phosphorylation in Macrophages Stimulated with Lipopolysaccharide.The specificity of protection against cationic antimicrobial peptides by lactoferrin binding protein B.Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial.Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.Antimicrobial Peptides: An Introduction.Wound-Healing Peptides for Treatment of Chronic Diabetic Foot Ulcers and Other Infected Skin Injuries.Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model.Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.Mechanism of Hbγ-35-induced an increase in the activation of the human immune system by endotoxins.Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds.In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design.

P2860

Q26765450-612A129C-53A1-43C2-86F1-2E5D2DDBF5E0 Q28488709-FB94E96A-5E4C-4D92-9677-F9524B615F2B Q28546464-22D057C4-411A-4310-AB27-9F5362463074 Q28548287-ABD83CDF-04D0-4364-B422-D2D6C5539C5F Q33700825-CB6A2D97-AC6A-41E0-BAA1-2ED1AAF73CBB Q33731274-B3E2CEF9-D953-4C22-AE38-BABD393FE99A Q34058299-387880F3-C95F-43D0-B0CD-EF9E7051A097 Q34447679-5BBB1DCE-97B8-44B2-8012-456E1E2FE433 Q34507671-FAD0A050-B042-4D22-9ABF-AA55A01D24B4 Q34544517-924350B8-C516-498F-A414-D441EFFA7B85 Q34769341-9002DC53-4618-41D5-8710-04FCF35DEAEF Q35163990-75BF41D7-834C-4D41-8EAF-6A283CF907FD Q35912382-6F77EFDD-DB4D-4D3E-8913-24F171455BA5 Q36090102-A9FE42D7-6AD7-45DA-B32D-374DC74D74A0 Q36183973-BAD68516-CF77-4919-8DAE-A8AD340E3B59 Q37598400-6C30121F-72E6-4BA4-9177-7F24182A5530 Q37696015-F29761DF-67BE-415B-B65A-FF9FB60D0EB8 Q38162670-30F65401-BF7B-46F1-AB22-5EF9594576FC Q38263995-BA3738D8-7BF8-49F8-B879-7C8869234187 Q38401924-829D1EF9-B3AB-416B-9400-38628B58EDD2 Q38967477-84941A48-6A63-4C74-ACD4-A6388693FE27 Q39011788-1C1F3345-BA36-40D4-AABB-2FDC3283B811 Q40594176-F4157C3F-E2D0-4EA1-86AD-008F13C40842 Q41577433-414A21F8-9685-428F-AA3B-45F7D0DFD0C6 Q42014234-CD2BBC45-7F0C-4C92-A0B9-98EB5E314056 Q42205540-9CCD877A-9F01-41E4-9558-12314432F3C5 Q42672939-1FC23E69-FD73-4D82-A677-6118DFDF4075 Q47118800-FB555B04-24F4-499F-8409-F7C3EC7E3622 Q47375349-61A7F2FB-761D-40A4-B77B-B11B3D7E5735 Q48149164-19C85CC3-3586-4F9F-A8BC-7C315BD56459 Q48198173-EB54125E-E895-41E0-9A7D-335BE4F6A459 Q48219322-C1723BAD-27B5-4816-AF06-ECAB18FABA3E Q49996616-F8502581-EEC8-4900-A029-1A278FD73CAA Q52592947-B1E1A94D-C6EA-480E-A9BE-1183706FB507 Q52691351-C8836447-63AE-4FCD-8B5F-F7D11EA9B338

P2860

Innate defense regulator peptide 1018 in wound healing and wound infection

http://www.wikidata.org/entity/Q34373912

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Innate defense regulator peptide 1018 in wound healing and wound infection

@ast

Innate defense regulator peptide 1018 in wound healing and wound infection

@en

Innate defense regulator peptide 1018 in wound healing and wound infection

@nl

type

label

Innate defense regulator peptide 1018 in wound healing and wound infection

@ast

Innate defense regulator peptide 1018 in wound healing and wound infection

@en

Innate defense regulator peptide 1018 in wound healing and wound infection

@nl

prefLabel

Innate defense regulator peptide 1018 in wound healing and wound infection

@ast

Innate defense regulator peptide 1018 in wound healing and wound infection

@en

Innate defense regulator peptide 1018 in wound healing and wound infection

@nl

P1433

Q34373912-D67ACB81-3501-433A-8595-FE026478A078

P1476

Q34373912-44216874-4A68-4F26-B6EC-D926E7A14152

P2093

Q34373912-03C320ED-12DD-4B14-8CF0-E6222C82B451

Q34373912-08ADCCC6-1E72-4C93-8A03-E983994EDCD2

Q34373912-26009E21-8760-429E-BE6B-212135C7186A

Q34373912-38CEAF53-62B9-4D98-A9A5-11D5A44C51F5

Q34373912-6E244A8E-4580-4660-A28F-306AD407961F

Q34373912-7150BE79-B5E6-4FAD-8D35-7CCF29B16C44

Q34373912-92FF14D2-3478-4207-95CD-47EFA62209E5

Q34373912-9B41B05C-D04E-4940-BAB0-E72F7FAD4E9E

Q34373912-F76F5D43-435D-4ECD-8730-56394E9912D0

Q34373912-FB9BB830-930E-4FFC-ADFF-F4BB131B8ED7

P2860

Q34373912-226CDEBD-CCEB-4210-AE89-25F128B8372D

Q34373912-2308B8EE-D579-4314-8B6F-A6FBDA64C093

Q34373912-2483A538-4473-4D8D-9BA9-61462D3E2E7D

Q34373912-2B10F464-02B3-4827-8B67-E8F48B09663D

Q34373912-2E64BB2F-844B-43BD-BD67-0DBF21B6E2FF

Q34373912-3BCB204D-4C49-4DC2-BE66-20A17FBF250B

Q34373912-4C7E17D0-955A-4738-BBF5-EBA0FC521307

Q34373912-55D7D093-850D-46A9-85FA-56E1AA47CB78

Q34373912-59624920-84CD-49A9-930A-A466FC82DEEB

Q34373912-5D540EF8-93FC-4706-84A6-4FC60F06A6F4

P304

Q34373912-3BB2C0C1-6DD9-484D-8D8D-1D6C68040148

P31

Q34373912-D5D3C6FA-8D38-41FA-A534-309C1DB16050

P356

Q34373912-173EE49F-BF08-443E-9DF0-E13C600D5CC7

P407

Q34373912-C36D7E38-B607-403E-8A7D-4DF059F73061

P433

Q34373912-4C10F5C0-D9F2-4969-BF44-D69181717AC4

P478

Q34373912-F43CEFDF-D9B5-47E8-8DC7-4CE421CC14DF

P50

Q34373912-44260DD2-D15A-4F76-835C-383C245DC5A0

Q34373912-B0EEDCF4-D7F6-4874-8B1A-C1C87DD15C24

P577

Q34373912-2EDA00E8-B9B9-474C-872B-2E6A9E980394

P5875

Q34373912-7C92B234-FBAE-4169-B3A5-741AB37376C7

P698

Q34373912-A84FE014-F479-437E-AB77-B1D52EBF12E9

P932

Q34373912-CA41A991-5B34-4FE1-9B98-7D49B3AEE674

P356

JOURNAL.PONE.0039373

P1433

P1476

Innate defense regulator peptide 1018 in wound healing and wound infection

@en

P2093

Evgenija A Mersch

http://www.w3.org/2001/XMLSchema#string

Frank Jacobsen

http://www.w3.org/2001/XMLSchema#string

Havard Jenssen

http://www.w3.org/2001/XMLSchema#string

Ingo Stricker

http://www.w3.org/2001/XMLSchema#string

Jason Kindrachuk

http://www.w3.org/2001/XMLSchema#string

Lars Steinstraesser

http://www.w3.org/2001/XMLSchema#string

Matthias Schulte

http://www.w3.org/2001/XMLSchema#string

Maximilian Kueckelhaus

http://www.w3.org/2001/XMLSchema#string

Nicole Afacan

http://www.w3.org/2001/XMLSchema#string

Tobias Hirsch

http://www.w3.org/2001/XMLSchema#string

P2860

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

Cutaneous wound healing

Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.

Synthetic cationic peptide IDR-1002 provides protection against bacterial infections through chemokine induction and enhanced leukocyte recruitment.

Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.

Cellular and molecular basis of wound healing in diabetes.

Host defense peptides as effector molecules of the innate immune response: a sledgehammer for drug resistance?

Biology and clinical relevance of naturally occurring antimicrobial peptides.

P304

e39373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0039373

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Jason Kindrachuk

Robert E. W. Hancock

P577

2012-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230645913

http://www.w3.org/2001/XMLSchema#string

P698

22879874

http://www.w3.org/2001/XMLSchema#string

P932

3412849

http://www.w3.org/2001/XMLSchema#string